Insider Trading Activity For CME Group Inc (NASDAQ:CME)
Ronald A Pankau , Director of CME Group Inc (NASDAQ:CME) reportedly Sold 250 shares of the company’s stock at an average price of 171.51 for a total transaction amount of $42,877.50 SEC Form
Insider Trading History For CME Group Inc (NASDAQ:CME)
Analyst Ratings History For CME Group Inc (NASDAQ:CME)
- On 1/31/2017 JPMorgan Chase & Co. Downgraded rating Overweight ➝ Neutral
- On 3/13/2017 Clarus Securities Reiterated Rating Buy
- On 6/12/2017 AltaCorp Capital Downgraded rating Outperform ➝ Speculative
- On 7/17/2017 Jefferies Group Reiterated Rating Buy with a price target of $128.00 ➝ $134.00
- On 9/6/2017 UBS Group Reiterated Rating Buy with a price target of $134.00 ➝ $135.00
- On 9/21/2017 Keefe, Bruyette & Woods Reiterated Rating Hold with a price target of $133.00
- On 10/4/2017 Wells Fargo & Co Boost Price Target of rating Market Perform with a price target of $130.00 ➝ $145.00
Dividend Information For CME Group Inc (NASDAQ:CME)
CME Group Inc (NASDAQ:CME) pays an annual dividend of $2.80 with a yield of 1.64%
Dividend History For CME Group Inc (NASDAQ:CME)
Recent Trading Activity for CME Group Inc (NASDAQ:CME)
Shares of CME Group Inc closed the previous trading session at 170.41 down -1.33 0.77% with 717295 shares trading hands.